1. Home
  2. MKTW vs SCLX Comparison

MKTW vs SCLX Comparison

Compare MKTW & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MKTW
  • SCLX
  • Stock Information
  • Founded
  • MKTW 1999
  • SCLX 2011
  • Country
  • MKTW United States
  • SCLX United States
  • Employees
  • MKTW N/A
  • SCLX N/A
  • Industry
  • MKTW Computer Software: Prepackaged Software
  • SCLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • MKTW Technology
  • SCLX Health Care
  • Exchange
  • MKTW Nasdaq
  • SCLX Nasdaq
  • Market Cap
  • MKTW 30.3M
  • SCLX 28.4M
  • IPO Year
  • MKTW N/A
  • SCLX N/A
  • Fundamental
  • Price
  • MKTW $15.76
  • SCLX $4.19
  • Analyst Decision
  • MKTW
  • SCLX Strong Buy
  • Analyst Count
  • MKTW 0
  • SCLX 4
  • Target Price
  • MKTW N/A
  • SCLX $396.67
  • AVG Volume (30 Days)
  • MKTW 28.3K
  • SCLX 206.3K
  • Earning Date
  • MKTW 05-08-2025
  • SCLX 05-23-2025
  • Dividend Yield
  • MKTW 4.68%
  • SCLX N/A
  • EPS Growth
  • MKTW 207.28
  • SCLX N/A
  • EPS
  • MKTW 3.12
  • SCLX N/A
  • Revenue
  • MKTW $383,217,000.00
  • SCLX $56,590,000.00
  • Revenue This Year
  • MKTW N/A
  • SCLX $115.30
  • Revenue Next Year
  • MKTW $0.42
  • SCLX $73.33
  • P/E Ratio
  • MKTW $5.06
  • SCLX N/A
  • Revenue Growth
  • MKTW N/A
  • SCLX 21.07
  • 52 Week Low
  • MKTW $9.08
  • SCLX $3.60
  • 52 Week High
  • MKTW $33.60
  • SCLX $80.50
  • Technical
  • Relative Strength Index (RSI)
  • MKTW 68.74
  • SCLX 33.31
  • Support Level
  • MKTW $13.01
  • SCLX $3.92
  • Resistance Level
  • MKTW $16.12
  • SCLX $6.13
  • Average True Range (ATR)
  • MKTW 0.90
  • SCLX 0.70
  • MACD
  • MKTW 0.19
  • SCLX 0.10
  • Stochastic Oscillator
  • MKTW 89.63
  • SCLX 12.21

About MKTW MarketWise Inc.

Marketwise Inc is a multi-brand subscription services platform providing premium financial research, software, education, and tools for investors. Its products are built for high-value financial research, education, actionable investment ideas, and investment software. It is a digital, direct-to-consumer company offering its research across a variety of platforms including mobile, desktops, and tablets.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: